Ganciclovir sodium

更昔洛韦钠

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameGanciclovir sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymerase
Therapy Area/IndicationsCytomegalovirus InfectionsCytomegalovirus Retinitis
Global Approved IndicationsCytomegalovirus InfectionsCytomegalovirus Retinitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCytomegalovirus InfectionsCytomegalovirus Retinitis

Other Information

ATC CodeJ05AB06S01AD09
Related LinksN/A